Ditto Bio
Health Care · Immunology & Inflammation Therapeutics
Funding and backers
Team
11-50
employees, estimated range
Backers
2
Y Combinator, Multimodal Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Hacker News stories
1
best: 1 points
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Cullinan Therapeutics, Elpiscience
backs Oblenio Bio
Similar startupsby what they do, their industry and backers
ImmuneSensor Therapeutics | Harnessing the innate immune system to treat inflammation, autoimmune disease and cancer.
Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
Oblenio Bio is pursuing broad immune reset as a transformative therapy for refractory autoimmune diseases through our LBL-051 T-cell…
Valora Therapeutics is developing AbLec™ multispecific antibodies and T-Lec™ T cell engagers — antibody-engineering platforms that decoy…
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune…
About Elpiscience is a clinical-stage biopharmaceutical company dedicated to the development of innovative immunotherapies for oncology and…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Multimodal VenturesVia a fund
Y CombinatorVia a fund
6310 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Mapping parasite molecules to treat autoimmune disease Ditto Bio
How we use parasite biology and our MoleculeMapper platform to improve target selection for autoimmune disease - including a viral molecule that invented the same mechanism as a blockbuster drug.
Read more
Report
Launch YC: Ditto Bio - Evolutionary therapies for autoimmune disease Y Combinator
We discover new drugs by harnessing parasite biology
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
10-50 est. staff